Paolo Pucci

CIK 1436861 · Chief Executive Officer · last filed 2026-05-06

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$0

Companies

5

Total Filings

80

Lifetime Open-Market Net

-$206.3K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
WSTw Director 11,854 $0 12 2026-05-06
REPL Director $8.88 $0 7 2026-04-07
Merus N.V. (MRUS) Delisted Director $90.00 $0 7 2025-12-12
LUMOS PHARMA, INC. (NLNK) Delisted Director $0 3 2018-05-25
DYAX CORP (DYAX) Delisted Director 0 -$206.3K 6 2016-01-22

Recent Filings · Page 5 of 8

80 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2017-08-31 Buy (P) +300 $315
2017-08-29 Buy (P) +2,970 $3.1K
2017-08-28 Buy (P) +9,492 $9.9K
2017-05-16 LUMOS PHARMA, INC. (NLNK) Delisted Grant (A) $0 EDGAR
2017-05-03 WSTw Grant (A) +1,697 $0 EDGAR
2017-01-18 Grant (A) $0
2016-10-04 WSTw Grant (A) $0 EDGAR
2016-09-13 WSTw Grant (A) +1,277 $0 EDGAR
2016-08-11 LUMOS PHARMA, INC. (NLNK) Delisted Grant (A) $0 EDGAR
2016-03-04 Exer (M) +97,498 $113.1K
Showing 4150 of 80
Page 5 of 8
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.